New routes in healthcare: BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM AG publish “MedTech Radar 7”
November 14, 2016
There is a growing need for innovation in the health system, but at the same time it is challenging to establish new healthcare solutions for the market. Many stakeholders such as insurance companies, investors and start-ups currently opt for alternative methods to achieve their goals. In its seventh issue, the media service “MedTech Radar”, a joint publication of the German Medical Technology Association BVMed, Earlybird Venture Capital, the High-Tech Gründerfonds and BIOCOM AG, reports on the major developments and trends that drive the medtech sector nowadays. MedTech Radar is available to download in German and English as a PDF file.
The healthcare sector is facing a massive transition. On the one hand, demographical change and an increase in lifestyle diseases drives healthcare-related costs to new highs. On the other hand, there are numerous companies working on innovative solutions that could remedy this situation. Market entry is a challenge, however, in particular for young companies. The new issue of MedTech Radar discusses how start-ups nevertheless achieve this and how insurance companies in partnership with investors try to accompany the development of new business models on their journey towards the market.
In an interview, Dr. Christoph Straub, Chairman of the Board at BARMER, and Thom Rasche, a partner at Earlybird, talk about why a statutory health insurance provider would act as a strategic investor in a venture capital fund. Furthermore, several start-ups are presented, whose approaches aim to follow new alternatives in healthcare. “The legal system and its requirements are unprepared for these new routes to improved healthcare and technologies. In addition, doctors need to have a change of heart, too, and start-ups need better infrastructure to bring their innovations to the market thus benefitting patients,” say Thom Rasche, a partner at Earlybird, and Dr. Michael Brandkamp, Managing Director of High-Tech Gründerfonds.
“The medtech industry is very research intensive. Products and methods are continuously improved in partnership with users and doctors. For the innovative capacity of the sector to continue, we need to readjust our reimbursement and evaluation systems according to the dynamic of technologies, so that we can immediately ensure that future patients will begin to profit from these. The MedTech Radar acts as an important dialogue instrument for this,” says Joachim Schmitt, Executive Director of BVMed.
“Our information portal medtech-zwo.de focuses on innovations in medical technology and start-ups in the German speaking areas of Europe. With the help of MedTech Radar, we would like to contribute towards highlighting the role of a dynamic climate for healthcare companies” says Dr. Boris Mannhardt, CEO of BIOCOM AG. The current issue of MedTech Radar will be available at BIOCOM AG’s booth (Hall 15, G42) at MEDICA 2016 which takes place from 14th to 17th November in Düsseldorf.
About the Publishers:
High-Tech Gründerfonds invests risk capital in young, up-and-coming technology companies that convert promising research results into business strategies.
Earlybird Venture Capital is one of the most successful venture capital investors in Europe currently managing over 700 million euros of capital for international investors.
The German Medical Technology Association (BVMed) is an industry association that represents over 230 industrial and commercial companies in the medical technology sector.
As an information specialist, BIOCOM AG has accompanied the life sciences with journals, websites and books for more than 30 years. The news portal medtech-zwo.de reports on start-ups, deals and financing related to the medtech sectors of Germany, Austria and Switzerland.
V.i.S.d.P:
BVMed – Bundesverband Medizintechnologie, Reinhardtstr. 29 b, 10117 Berlin
Manfred Beeres, Leiter Kommunikation/Presse; Tel. +49 – 30 246 255-20, beeres@bvmed.de, www.bvmed.de
Earlybird Venture Capital, Münzstr. 21, 10178 Berlin
Catrin Schmidt; Tel. +49 – 30 46724700, catrin@earlybird.com, https://www.earlybird.com
High-Tech Gründerfonds Management GmbH, Schlegelstraße 2, 53113 Bonn
Stefanie Zillikens; Tel. +49 – 228 82300107, s.zillikens@htgf.de, https://www.htgf.de/en/
BIOCOM AG, Lützowstr. 33-36, 10785 Berlin,
Sandra Wirsching, Redaktionsleiterin; Tel.: +49 (0)30-264 921-63 | s.wirsching@biocom.de, www.biocom.de
Stay up to date
Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!
Scavenger AI secures €1.1m pre-seed funding for data-driven decision making
Proxima Fusion Raises €20M Seed to Accelerate Timeline to Fusion Power
